Loading...
Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients
Despite the efficacy of decitabine to myelodysplastic syndrome (MDS), there is a wide range of responses, and no definite predictive marker has been identified. This study aimed to describe the efficacy of decitabine and to identify potential predictors of response and survival in patients with MDS....
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599296/ https://ncbi.nlm.nih.gov/pubmed/25938546 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|